| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 79,984,722 | 91,596,173 | 77,419,445 | | Cost of Revenue | 58,373,056 | 64,410,124 | 54,352,553 | | | Gross Profit | 21,611,666 | 27,186,049 | 23,066,892 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 20,861,074 | 23,750,009 | 19,160,794 | | Non Recurring |
-
|
-
| 259,216 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 750,592 | 3,436,040 | 3,646,883 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (4,492,046) | 1,162,995 | 263,543 | | Earnings Before Interest And Taxes | (3,741,454) | 4,599,035 | 3,910,425 | | Interest Expense | 199,676 | 205,606 | 177,701 | | Income Before Tax | (3,941,130) | 4,393,429 | 3,732,724 | | Income Tax Expense | 384,787 | 1,157,187 | 1,630,836 | | Minority Interest | 256,285 | (289,234) | (264,614) | | | | Net Income From Continuing Ops | (3,903,298) | 2,846,958 | 1,846,073 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (3,903,298) | 2,846,958 | 1,846,073 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($3,903,298) | $2,846,958 | $1,846,073 |
|
0.51% Nasdaq 
Income Statement
